S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
Log in
NYSE:CLB

Core Laboratories Stock Forecast, Price & News

$33.75
-1.71 (-4.82 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$32.23
Now: $33.75
$35.21
50-Day Range
$21.97
MA: $27.56
$35.46
52-Week Range
$6.68
Now: $33.75
$40.77
Volume568,194 shs
Average Volume490,559 shs
Market Capitalization$1.50 billion
P/E RatioN/A
Dividend Yield0.11%
Beta3.38
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Core Laboratories logo

MarketRank

Overall MarketRank

1.55 out of 5 stars

Oils/Energy Sector

122nd out of 517 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

6th out of 38 stocks

Analyst Opinion: 1.1Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
CUSIPN/A
Phone31-20-420-3191
Employees4,300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$668.21 million
Cash Flow$2.51 per share
Book Value$4.10 per share

Profitability

Net Income$101.98 million

Miscellaneous

Market Cap$1.50 billion
Next Earnings Date1/27/2021 (Confirmed)
OptionableOptionable
$33.75
-1.71 (-4.82 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Core Laboratories (NYSE:CLB) Frequently Asked Questions

How has Core Laboratories' stock been impacted by COVID-19 (Coronavirus)?

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CLB stock has increased by 208.8% and is now trading at $33.75.
View which stocks have been most impacted by COVID-19
.

Is Core Laboratories a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Core Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View analyst ratings for Core Laboratories
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Core Laboratories?

Wall Street analysts have given Core Laboratories a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Core Laboratories wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, January 27th 2021.
View our earnings forecast for Core Laboratories
.

How can I listen to Core Laboratories' earnings call?

Core Laboratories will be holding an earnings conference call on Wednesday, January 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) posted its quarterly earnings data on Wednesday, October, 21st. The oil and gas company reported $0.16 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.14 by $0.02. The oil and gas company earned $105.38 million during the quarter, compared to analysts' expectations of $109.33 million. Core Laboratories had a negative net margin of 19.02% and a positive return on equity of 45.39%. Core Laboratories's quarterly revenue was down 39.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.50 earnings per share.
View Core Laboratories' earnings history
.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Thursday, October 15th. Investors of record on Monday, October 26th will be paid a dividend of $0.01 per share on Tuesday, November 17th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.12%. The ex-dividend date of this dividend is Friday, October 23rd.
View Core Laboratories' dividend history
.

Is Core Laboratories a good dividend stock?

Core Laboratories pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.11%. The dividend payout ratio of Core Laboratories is 2.23%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.55% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

What price target have analysts set for CLB?

13 equities research analysts have issued 12 month price targets for Core Laboratories' shares. Their forecasts range from $11.00 to $30.00. On average, they anticipate Core Laboratories' share price to reach $21.22 in the next year. This suggests that the stock has a possible downside of 37.1%.
View analysts' price targets for Core Laboratories
or view Wall Street analyst' top-rated stocks.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:
  • Mr. Lawrence V. Bruno, Chairman, CEO, Pres & COO (Age 61, Pay $1.28M)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 51, Pay $448.02k)
  • Mr. David M. Demshur, Exec. Officer (Age 66, Pay $2.36M)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 57)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations
  • Mr. Mark F. Elvig, Sr. VP, Gen. Counsel & Sec. (Age 62)
  • Mr. Jacobus Schouten, Managing Director (Age 66)
  • J. Donald Dumas Jr., Sr. VP of Production Enhancement & Bus. Devel.

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Douglas Lane & Associates LLC (1.50%), Scout Investments Inc. (0.16%), Kopion Asset Management LLC (0.10%) and State of Alaska Department of Revenue (0.08%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories
.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue.
View insider buying and selling activity for Core Laboratories
or view top insider-selling stocks.

Which major investors are buying Core Laboratories stock?

CLB stock was purchased by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Kopion Asset Management LLC, and Scout Investments Inc.. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories
or or view top insider-buying stocks.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $33.75.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $1.50 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.

What is Core Laboratories' official website?

The official website for Core Laboratories is www.corelab.com.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]

This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.